Immediate Airway and Monitoring for Acute Uvular Edema
Acute uvular edema should be managed as a potential upper-airway emergency until airway stability is confirmed. [1] Airway patency should be the primary management priority when uvular swelling is accompanied by any signs of laryngeal or posterior pharyngeal involvement or respiratory compromise. [1]
Emergency Triage for Histamine-Mediated Allergy Versus Bradykinin-Mediated Angioedema
Acute uvular edema with rapid progression and/or concomitant mucosal swelling should be treated as possible anaphylaxis or allergic angioedema until excluded. [1] Isolated uvular edema caused by bradykinin-mediated angioedema (e.g., ACE-inhibitor–related angioedema) should be considered when urticaria is absent and triggers include ACE-inhibitor use. [2]
Medication Selection for Suspected Anaphylaxis
Parenteral epinephrine should not be delayed when anaphylaxis is suspected. [1] Antihistamines and corticosteroids should be used only as adjunctive therapy and should not replace epinephrine in anaphylaxis management. [1] Adjunctive antihistamines and corticosteroids can be administered after epinephrine when anaphylaxis is suspected. [1]
Medication Selection for Suspected Acquired (Bradykinin-Mediated) Angioedema
Initial medical management for acquired angioedema should include supplemental oxygen, a parenteral H1-blocker, a parenteral steroid, and intramuscular epinephrine. [2] Standard anaphylaxis regimens of epinephrine, corticosteroids, and antihistamines have limited effectiveness in acquired angioedema and are not recommended as definitive therapy for acquired angioedema. [2] Targeted bradykinin-pathway therapy should be used when available (including C1-inhibitor replacement or bradykinin B2 receptor antagonism). [2]
Infectious Uvulitis and Non–Life-Threatening Swelling Management
When uvular edema is attributed to uvulitis, treatment should be directed at the cause and should include antibiotics for infection, steroids for swelling reduction, antihistamines for allergic causes, and reflux-directed therapy for reflux-related irritation. [3] Supportive measures for non–life-threatening uvulitis include rest, oral hydration, warm salt-water gargles, and symptomatic pain relief. [3]
Procedural and Disposition Management for Airway Risk
Patients with persistent tongue, intraoral, or throat involvement or persistent or recurrent airway edema should require intensive care admission. [2] Close monitoring and rapid reassessment should be performed because clinical course can deteriorate despite initial treatment. [2] When severe swelling threatens choking or breathing, airway intervention may be required to open the airway. [3]
Pitfalls to Avoid
Antihistamines and corticosteroids should not be used as substitutes for epinephrine in suspected anaphylaxis. [1] Airway management decisions should not be deferred when posterior pharyngeal or laryngeal involvement is suspected. [1]
Targets for Therapy
The immediate therapeutic goal is preservation of airway patency with ongoing monitoring for progression of upper-airway edema. [1] The secondary therapeutic goal is rapid initiation of cause-directed therapy based on whether the process is histamine-mediated (treat as anaphylaxis) or bradykinin-mediated (treat as acquired angioedema with targeted therapy when available). [1] [2]